CXCL8 and gastric cancer: To further confirm the role of IL‐8 in increasing the motility activity in gastric cancer cells, we treated AGS and CS12 cells with various concentrations (0, 1, 10, 20, 50 and 100 ng/ml) of recombinant IL‐8 for 24 hrs.